• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KLRG1与E-钙黏蛋白的相互作用:新的功能和结构见解

Interaction of KLRG1 with E-cadherin: new functional and structural insights.

作者信息

Rosshart Stephan, Hofmann Maike, Schweier Oliver, Pfaff Anne-Kathrin, Yoshimoto Keiko, Takeuchi Tsutomu, Molnar Eszter, Schamel Wolfgang W, Pircher Hanspeter

机构信息

Department of Immunology, Institute of Medical Microbiology and Hygiene, University of Freiburg, Germany.

出版信息

Eur J Immunol. 2008 Dec;38(12):3354-64. doi: 10.1002/eji.200838690.

DOI:10.1002/eji.200838690
PMID:19009530
Abstract

The killer cell lectin-like receptor G1 (KLRG1) is an inhibitory receptor expressed by memory T cells and NK cells in man and mice. It is frequently used as a cell differentiation marker and members of the cadherin family are ligands for KLRG1. The present study provides new insights into the interaction of mouse KLRG1 with E-cadherin. Firstly, we demonstrate that co-engagement of KLRG1 and CD3/TCR in a spatially linked manner was required for inhibition arguing against the notion that KLRG1-ligation per se transmits inhibitory signals. Secondly, experiments with T cells carrying Y(7)F-mutant KLRG1 molecules with a replacement of the tyrosine residue to phenylalanine in the single ITIM indicated that the inhibitory activity of KLRG1 is counteracted to some degree by increased interaction of KLRG1(+) T cells with E-cadherin expressing target cells. Thirdly, we demonstrate that deletion of the first or the second external domain of E-cadherin abolished reactivity in KLRG1-reporter cell assays. Finally, we made the intriguing observation that KLRG1 formed multimeric protein complexes in T cells in addition to the previously described mono- and dimeric molecules.

摘要

杀伤细胞凝集素样受体G1(KLRG1)是一种抑制性受体,在人和小鼠的记忆T细胞和自然杀伤细胞中表达。它经常被用作细胞分化标志物,钙黏蛋白家族成员是KLRG1的配体。本研究为小鼠KLRG1与E-钙黏蛋白的相互作用提供了新的见解。首先,我们证明KLRG1和CD3/TCR以空间连接的方式共同参与抑制作用,这与KLRG1自身结合传递抑制信号的观点相悖。其次,对携带Y(7)F突变型KLRG1分子的T细胞进行实验,该分子在单个免疫受体酪氨酸抑制基序中将酪氨酸残基替换为苯丙氨酸,结果表明KLRG1(+) T细胞与表达E-钙黏蛋白的靶细胞之间相互作用增加,在一定程度上抵消了KLRG1的抑制活性。第三,我们证明在KLRG1报告细胞试验中,E-钙黏蛋白第一或第二胞外结构域的缺失消除了反应性。最后,我们有一个有趣的发现,即除了先前描述的单体和二聚体分子外,KLRG1在T细胞中还形成多聚体蛋白复合物。

相似文献

1
Interaction of KLRG1 with E-cadherin: new functional and structural insights.KLRG1与E-钙黏蛋白的相互作用:新的功能和结构见解
Eur J Immunol. 2008 Dec;38(12):3354-64. doi: 10.1002/eji.200838690.
2
Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.杀伤细胞凝集素样受体G1结合经典钙黏蛋白家族的三个成员以抑制自然杀伤细胞的细胞毒性。
J Exp Med. 2006 Feb 20;203(2):289-95. doi: 10.1084/jem.20051986. Epub 2006 Feb 6.
3
The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.自然杀伤细胞受体 KLRG1 在体内病毒诱导的自然杀伤细胞和 CD8+ T 细胞分化和功能中是可有可无的。
Eur J Immunol. 2010 May;40(5):1303-14. doi: 10.1002/eji.200939771.
4
Functional plasticity and robustness are essential characteristics of biological systems: lessons learned from KLRG1-deficient mice.功能性可塑性和鲁棒性是生物系统的重要特征:从 KLRG1 缺陷小鼠中得到的启示。
Eur J Immunol. 2010 May;40(5):1241-3. doi: 10.1002/eji.201040506.
5
KLRG1 binds cadherins and preferentially associates with SHIP-1.杀伤细胞凝集素样受体亚家族G成员1(KLRG1)结合钙黏着蛋白,并优先与SHIP-1相互作用。
Int Immunol. 2007 Apr;19(4):391-400. doi: 10.1093/intimm/dxm004. Epub 2007 Feb 16.
6
Different inhibitory capacities of human and mouse KLRG1 are linked to distinct disulfide-mediated oligomerizations.人源和鼠源 KLRG1 的不同抑制能力与其独特的二硫键介导的寡聚化相关。
Eur J Immunol. 2012 Sep;42(9):2484-90. doi: 10.1002/eji.201142357. Epub 2012 Jul 27.
7
Tumor-associated E-cadherin mutations affect binding to the killer cell lectin-like receptor G1 in humans.肿瘤相关的E-钙黏蛋白突变影响人类杀伤细胞凝集素样受体G1的结合。
J Immunol. 2007 Jul 15;179(2):1022-9. doi: 10.4049/jimmunol.179.2.1022.
8
Molecular basis for E-cadherin recognition by killer cell lectin-like receptor G1 (KLRG1).杀伤细胞凝集素样受体G1(KLRG1)识别E-钙黏蛋白的分子基础。
J Biol Chem. 2009 Oct 2;284(40):27327-35. doi: 10.1074/jbc.M109.038802. Epub 2009 Aug 4.
9
Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1).人类Vγ9/Vδ2效应记忆T细胞表达杀伤细胞凝集素样受体G1(KLRG1)。
J Leukoc Biol. 2005 Jan;77(1):67-70. doi: 10.1189/jlb.0204096. Epub 2004 Oct 21.
10
TGF-β downregulates KLRG1 expression in mouse and human CD8(+) T cells.转化生长因子-β下调小鼠和人类CD8(+) T细胞中的杀伤细胞凝集素样受体G1(KLRG1)表达。
Eur J Immunol. 2015 Aug;45(8):2212-7. doi: 10.1002/eji.201545634. Epub 2015 Jun 15.

引用本文的文献

1
Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges.上皮-间质转化调控肿瘤微环境:当前认知与挑战
J Transl Med. 2025 Apr 2;23(1):386. doi: 10.1186/s12967-025-06422-5.
2
Single-cell RNA-sequencing of human spleens reveals an IDO-1 tolerogenic dendritic cell subset in pancreatic cancer patients that is absent in normal individuals.单细胞 RNA 测序分析人类脾脏揭示,胰腺癌患者中的 IDO-1 耐受性树突状细胞亚群在正常个体中不存在。
Cancer Lett. 2024 Dec 28;607:217321. doi: 10.1016/j.canlet.2024.217321. Epub 2024 Nov 14.
3
Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review.
嵌合抗原受体T细胞(CAR-T)疗法中基因编辑技术的进展与陷阱:最新综述
Front Oncol. 2024 Jun 7;14:1388475. doi: 10.3389/fonc.2024.1388475. eCollection 2024.
4
The role of KLRG1: a novel biomarker and new therapeutic target.KLRG1 的作用:一种新型生物标志物和新的治疗靶点。
Cell Commun Signal. 2024 Jun 19;22(1):337. doi: 10.1186/s12964-024-01714-7.
5
KLRG1-expressing CD8+ T cells are exhausted and polyfunctional in patients with chronic hepatitis B.表达 KLGR1 的 CD8+ T 细胞在慢性乙型肝炎患者中处于耗竭和多功能状态。
PLoS One. 2024 May 22;19(5):e0303945. doi: 10.1371/journal.pone.0303945. eCollection 2024.
6
KLRG1 Cell Depletion as a Novel Therapeutic Strategy in Patients with Mature T-Cell Lymphoma Subtypes.KLRG1 细胞耗竭作为一种新的治疗策略在成熟 T 细胞淋巴瘤亚型患者中的应用。
Clin Cancer Res. 2024 Jun 3;30(11):2514-2530. doi: 10.1158/1078-0432.CCR-23-3504.
7
Strategies for overcoming bottlenecks in allogeneic CAR-T cell therapy.克服同种异体 CAR-T 细胞治疗瓶颈的策略。
Front Immunol. 2023 Jul 24;14:1199145. doi: 10.3389/fimmu.2023.1199145. eCollection 2023.
8
The diverse effects of transforming growth factor-β and SMAD signaling pathways during the CTL response.CTL 应答过程中转化生长因子-β和 SMAD 信号通路的多样化效应。
Front Immunol. 2023 Jun 23;14:1199671. doi: 10.3389/fimmu.2023.1199671. eCollection 2023.
9
Tumor necroptosis-mediated shedding of cell surface proteins promotes metastasis of breast cancer by suppressing anti-tumor immunity.肿瘤坏死性凋亡介导的细胞表面蛋白脱落通过抑制抗肿瘤免疫促进乳腺癌转移。
Breast Cancer Res. 2023 Jan 26;25(1):10. doi: 10.1186/s13058-023-01604-9.
10
Phenotypic signatures of immune selection in HIV-1 reservoir cells.HIV-1 储库细胞中免疫选择的表型特征。
Nature. 2023 Feb;614(7947):309-317. doi: 10.1038/s41586-022-05538-8. Epub 2023 Jan 4.